Watts VJ - Search Results

1

WAY-100635 is a potent dopamine D4 receptor agonist.

Chemel BR, Roth BL, Armbruster B, Watts VJ, Nichols DE. Chemel BR, et al. Among authors: watts vj. Psychopharmacology (Berl). 2006 Oct;188(2):244-51. doi: 10.1007/s00213-006-0490-4. Epub 2006 Aug 17. Psychopharmacology (Berl). 2006. PMID: 16915381

2

"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.

Gilmore JH, Watts VJ, Lawler CP, Noll EP, Nichols DE, Mailman RB. Gilmore JH, et al. Among authors: watts vj. Neuropharmacology. 1995 May;34(5):481-8. doi: 10.1016/0028-3908(95)00014-w. Neuropharmacology. 1995. PMID: 7566481

3

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Watts VJ, Lawler CP, Fox DR, Neve KA, Nichols DE, Mailman RB. Watts VJ, et al. Psychopharmacology (Berl). 1995 Apr;118(4):401-9. doi: 10.1007/BF02245940. Psychopharmacology (Berl). 1995. PMID: 7568626

4

Synthesis and evaluation of 6,7-dihydroxy-2,3,4,8,9,13b-hexahydro-1H- benzo[6,7]cyclohepta[1,2,3-ef][3]benzazepine, 6,7-dihydroxy- 1,2,3,4,8,12b-hexahydroanthr[10,4a,4-cd]azepine, and 10-(aminomethyl)-9,10- dihydro-1,2-dihydroxyanthracene as conformationally restricted analogs of beta-phenyldopamine.

Snyder SE, Aviles-Garay FA, Chakraborti R, Nichols DE, Watts VJ, Mailman RB. Snyder SE, et al. Among authors: watts vj. J Med Chem. 1995 Jun 23;38(13):2395-409. doi: 10.1021/jm00013a015. J Med Chem. 1995. PMID: 7608904

5

Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.

Knoerzer TA, Watts VJ, Nichols DE, Mailman RB. Knoerzer TA, et al. Among authors: watts vj. J Med Chem. 1995 Aug 4;38(16):3062-70. doi: 10.1021/jm00016a009. J Med Chem. 1995. PMID: 7636869

6

Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.

Brewster WK, Nichols DE, Watts VJ, Riggs RM, Mottola D, Mailman RB. Brewster WK, et al. Among authors: watts vj. J Med Chem. 1995 Jan 20;38(2):318-27. doi: 10.1021/jm00002a013. J Med Chem. 1995. PMID: 7830274

7

Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.

Watts VJ, Lawler CP, Gilmore JH, Southerland SB, Nichols DE, Mailman RB. Watts VJ, et al. Eur J Pharmacol. 1993 Sep 28;242(2):165-72. doi: 10.1016/0014-2999(93)90076-t. Eur J Pharmacol. 1993. PMID: 7902811

8

Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.

Knoerzer TA, Nichols DE, Brewster WK, Watts VJ, Mottola D, Mailman RB. Knoerzer TA, et al. Among authors: watts vj. J Med Chem. 1994 Jul 22;37(15):2453-60. doi: 10.1021/jm00041a025. J Med Chem. 1994. PMID: 7914538

9

Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.

Minor DL, Wyrick SD, Charifson PS, Watts VJ, Nichols DE, Mailman RB. Minor DL, et al. Among authors: watts vj. J Med Chem. 1994 Dec 9;37(25):4317-28. doi: 10.1021/jm00051a008. J Med Chem. 1994. PMID: 7996543

10

Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.

Watts VJ, Lawler CP, Knoerzer T, Mayleben MA, Neve KA, Nichols DE, Mailman RB. Watts VJ, et al. Eur J Pharmacol. 1993 Aug 3;239(1-3):271-3. doi: 10.1016/0014-2999(93)91012-c. Eur J Pharmacol. 1993. PMID: 8223910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters